Founded in the year 2014 by Sujata Chaudhri and located in the National Capital Region (NCR) in India, our firm provides advisory, litigation and enforcement, and prosecution services in all areas of intellectual property law.
Recently, the Hon’ble Delhi High Court refused to cancel the registered trademark, REKIN-SP, of Rekin Pharma Private Limited (“Respondent”) in a cancellation petition filed by Rexcin Pharmaceuticals Private Limited (“Petitioner”). The Petitioner had filed the petition under Section 57 of the Trade Marks Act, 1999 (the “Act”), seeking removal of the Respondent’s registration for the mark, REKIN-SP in Class 5, on the grounds of prior rights and deceptive similarity of the riv
What Makes an Invention Patentable in India? This is an important question every inventor should understand. Many inventors believe that having a good idea automatically qualifies them for a patent. But in reality, this is not how patent protection works in India. Under Indian Patent Law, every invention must pass specific legal and technical tests before it can be granted a patent. Understanding these basics early can save time, money, and disappointment. So, what actually m
The Delhi High Court’s Division Bench has now pronounced its decision in Canva Pty Ltd & Ors v. RxPrism Health Systems Pvt Ltd & Anr, a significant moment for patent enforcement in the Indian SaaS and tech ecosystem, it is a wake-up call for both SaaS startups and IP practitioners navigating India’s evolving software-patent landscape. RxPrism, holder of Indian Patent IN 360726 for a system and method for creating and sharing interactive content through a layered architectur
